Equine Pharmaceuticals and Supplements Industry Research Report 2024
This report aims to provide a comprehensive presentation of the global market for Equine Pharmaceuticals and Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Pharmaceuticals and Supplements.
The Equine Pharmaceuticals and Supplements market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equine Pharmaceuticals and Supplements market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Pharmaceuticals and Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Equine Pharmaceuticals and Supplements type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Equine Pharmaceuticals and Supplements are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Equine Pharmaceuticals and Supplements segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Equine Pharmaceuticals and Supplements market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Equine Pharmaceuticals and Supplements market.
Equine Pharmaceuticals and Supplements segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Equine Pharmaceuticals and Supplements market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Equine Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Equine Pharmaceuticals and Supplements industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Pharmaceuticals and Supplements.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Equine Pharmaceuticals and Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Equine Pharmaceuticals and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The Equine Pharmaceuticals and Supplements market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equine Pharmaceuticals and Supplements market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Pharmaceuticals and Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Boehringer Ingelheim
- Merck Animal Health
- Zoetis
- Bayer Animal Health
- Elanco Animal Health
- Dechra Veterinary Products
- CEVA
- Virbac
- Norbrook Equine
- Kyoritsu Seiyaku
- Vetoquinol
- Protexin Healthcare
- Audevard
- Ouro Fino Saude
Global markets are presented by Equine Pharmaceuticals and Supplements type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Equine Pharmaceuticals and Supplements are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Equine Pharmaceuticals and Supplements segment by Type
- Pharmaceuticals
- Supplements
This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Equine Pharmaceuticals and Supplements market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Equine Pharmaceuticals and Supplements market.
Equine Pharmaceuticals and Supplements segment by Application
- Thoroughbred Horse
- Other Types of Horses
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Equine Pharmaceuticals and Supplements market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Pharmaceuticals and Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Equine Pharmaceuticals and Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Equine Pharmaceuticals and Supplements industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Pharmaceuticals and Supplements.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Equine Pharmaceuticals and Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Equine Pharmaceuticals and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Equine Pharmaceuticals and Supplements Market Size (2019-2030) & (US$ Million)
2.2.2 Global Equine Pharmaceuticals and Supplements Sales (2019-2030)
2.2.3 Global Equine Pharmaceuticals and Supplements Market Average Price (2019-2030)
2.3 Equine Pharmaceuticals and Supplements by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Pharmaceuticals
1.2.3 Supplements
2.4 Equine Pharmaceuticals and Supplements by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Thoroughbred Horse
2.4.3 Other Types of Horses
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Equine Pharmaceuticals and Supplements Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Equine Pharmaceuticals and Supplements Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Equine Pharmaceuticals and Supplements Revenue of Manufacturers (2019-2024)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2019-2024)
3.5 Global Equine Pharmaceuticals and Supplements Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Equine Pharmaceuticals and Supplements, Product Type & Application
3.8 Global Manufacturers of Equine Pharmaceuticals and Supplements, Date of Enter into This Industry
3.9 Global Equine Pharmaceuticals and Supplements Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Boehringer Ingelheim
4.1.1 Boehringer Ingelheim Company Information
4.1.2 Boehringer Ingelheim Business Overview
4.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
4.1.5 Boehringer Ingelheim Recent Developments
4.2 Merck Animal Health
4.2.1 Merck Animal Health Company Information
4.2.2 Merck Animal Health Business Overview
4.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
4.2.5 Merck Animal Health Recent Developments
4.3 Zoetis
4.3.1 Zoetis Company Information
4.3.2 Zoetis Business Overview
4.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
4.3.5 Zoetis Recent Developments
4.4 Bayer Animal Health
4.4.1 Bayer Animal Health Company Information
4.4.2 Bayer Animal Health Business Overview
4.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
4.4.5 Bayer Animal Health Recent Developments
4.5 Elanco Animal Health
4.5.1 Elanco Animal Health Company Information
4.5.2 Elanco Animal Health Business Overview
4.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
4.5.5 Elanco Animal Health Recent Developments
4.6 Dechra Veterinary Products
4.6.1 Dechra Veterinary Products Company Information
4.6.2 Dechra Veterinary Products Business Overview
4.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
4.6.5 Dechra Veterinary Products Recent Developments
4.7 CEVA
4.7.1 CEVA Company Information
4.7.2 CEVA Business Overview
4.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
4.7.5 CEVA Recent Developments
4.8 Virbac
4.8.1 Virbac Company Information
4.8.2 Virbac Business Overview
4.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
4.8.5 Virbac Recent Developments
4.9 Norbrook Equine
4.9.1 Norbrook Equine Company Information
4.9.2 Norbrook Equine Business Overview
4.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
4.9.5 Norbrook Equine Recent Developments
4.10 Kyoritsu Seiyaku
4.10.1 Kyoritsu Seiyaku Company Information
4.10.2 Kyoritsu Seiyaku Business Overview
4.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
4.10.5 Kyoritsu Seiyaku Recent Developments
6.11 Vetoquinol
6.11.1 Vetoquinol Company Information
6.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Business Overview
6.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
6.11.5 Vetoquinol Recent Developments
6.12 Protexin Healthcare
6.12.1 Protexin Healthcare Company Information
6.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Business Overview
6.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
6.12.5 Protexin Healthcare Recent Developments
6.13 Audevard
6.13.1 Audevard Company Information
6.13.2 Audevard Equine Pharmaceuticals and Supplements Business Overview
6.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
6.13.5 Audevard Recent Developments
6.14 Ouro Fino Saude
6.14.1 Ouro Fino Saude Company Information
6.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Business Overview
6.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
6.14.5 Ouro Fino Saude Recent Developments
5 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SCENARIO BY REGION
5.1 Global Equine Pharmaceuticals and Supplements Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2019-2030
5.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2019-2024
5.2.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2025-2030
5.3 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2019-2030
5.3.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2019-2024
5.3.2 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2025-2030
5.4 North America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.4.1 North America Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.4.3 North America Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.5.1 Europe Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.5.3 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.6.1 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.6.3 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.7.1 Latin America Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.7.3 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.8.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.8.3 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2019-2030)
6.1.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2019-2030) & (K Units)
6.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2030)
6.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2019-2030)
6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2019-2030)
6.3 Global Equine Pharmaceuticals and Supplements Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2030)
7.1.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2030) & (K Units)
7.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2030)
7.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2019-2030)
6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2019-2030)
7.3 Global Equine Pharmaceuticals and Supplements Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
8.1.1 Equine Pharmaceuticals and Supplements Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Equine Pharmaceuticals and Supplements Production Mode & Process
8.2 Equine Pharmaceuticals and Supplements Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Equine Pharmaceuticals and Supplements Distributors
8.2.3 Equine Pharmaceuticals and Supplements Customers
9 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS ANALYZING MARKET DYNAMICS
9.1 Equine Pharmaceuticals and Supplements Industry Trends
9.2 Equine Pharmaceuticals and Supplements Industry Drivers
9.3 Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges
9.4 Equine Pharmaceuticals and Supplements Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Equine Pharmaceuticals and Supplements Market Size (2019-2030) & (US$ Million)
2.2.2 Global Equine Pharmaceuticals and Supplements Sales (2019-2030)
2.2.3 Global Equine Pharmaceuticals and Supplements Market Average Price (2019-2030)
2.3 Equine Pharmaceuticals and Supplements by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Pharmaceuticals
1.2.3 Supplements
2.4 Equine Pharmaceuticals and Supplements by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Thoroughbred Horse
2.4.3 Other Types of Horses
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Equine Pharmaceuticals and Supplements Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Equine Pharmaceuticals and Supplements Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Equine Pharmaceuticals and Supplements Revenue of Manufacturers (2019-2024)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2019-2024)
3.5 Global Equine Pharmaceuticals and Supplements Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Equine Pharmaceuticals and Supplements, Product Type & Application
3.8 Global Manufacturers of Equine Pharmaceuticals and Supplements, Date of Enter into This Industry
3.9 Global Equine Pharmaceuticals and Supplements Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Boehringer Ingelheim
4.1.1 Boehringer Ingelheim Company Information
4.1.2 Boehringer Ingelheim Business Overview
4.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
4.1.5 Boehringer Ingelheim Recent Developments
4.2 Merck Animal Health
4.2.1 Merck Animal Health Company Information
4.2.2 Merck Animal Health Business Overview
4.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
4.2.5 Merck Animal Health Recent Developments
4.3 Zoetis
4.3.1 Zoetis Company Information
4.3.2 Zoetis Business Overview
4.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
4.3.5 Zoetis Recent Developments
4.4 Bayer Animal Health
4.4.1 Bayer Animal Health Company Information
4.4.2 Bayer Animal Health Business Overview
4.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
4.4.5 Bayer Animal Health Recent Developments
4.5 Elanco Animal Health
4.5.1 Elanco Animal Health Company Information
4.5.2 Elanco Animal Health Business Overview
4.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
4.5.5 Elanco Animal Health Recent Developments
4.6 Dechra Veterinary Products
4.6.1 Dechra Veterinary Products Company Information
4.6.2 Dechra Veterinary Products Business Overview
4.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
4.6.5 Dechra Veterinary Products Recent Developments
4.7 CEVA
4.7.1 CEVA Company Information
4.7.2 CEVA Business Overview
4.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
4.7.5 CEVA Recent Developments
4.8 Virbac
4.8.1 Virbac Company Information
4.8.2 Virbac Business Overview
4.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
4.8.5 Virbac Recent Developments
4.9 Norbrook Equine
4.9.1 Norbrook Equine Company Information
4.9.2 Norbrook Equine Business Overview
4.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
4.9.5 Norbrook Equine Recent Developments
4.10 Kyoritsu Seiyaku
4.10.1 Kyoritsu Seiyaku Company Information
4.10.2 Kyoritsu Seiyaku Business Overview
4.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
4.10.5 Kyoritsu Seiyaku Recent Developments
6.11 Vetoquinol
6.11.1 Vetoquinol Company Information
6.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Business Overview
6.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
6.11.5 Vetoquinol Recent Developments
6.12 Protexin Healthcare
6.12.1 Protexin Healthcare Company Information
6.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Business Overview
6.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
6.12.5 Protexin Healthcare Recent Developments
6.13 Audevard
6.13.1 Audevard Company Information
6.13.2 Audevard Equine Pharmaceuticals and Supplements Business Overview
6.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
6.13.5 Audevard Recent Developments
6.14 Ouro Fino Saude
6.14.1 Ouro Fino Saude Company Information
6.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Business Overview
6.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
6.14.5 Ouro Fino Saude Recent Developments
5 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SCENARIO BY REGION
5.1 Global Equine Pharmaceuticals and Supplements Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2019-2030
5.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2019-2024
5.2.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2025-2030
5.3 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2019-2030
5.3.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2019-2024
5.3.2 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2025-2030
5.4 North America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.4.1 North America Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.4.3 North America Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.5.1 Europe Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.5.3 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.6.1 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.6.3 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.7.1 Latin America Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.7.3 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
5.8.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2019-2030)
5.8.3 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2019-2030)
6.1.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2019-2030) & (K Units)
6.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2030)
6.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2019-2030)
6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2019-2030)
6.3 Global Equine Pharmaceuticals and Supplements Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2030)
7.1.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2030) & (K Units)
7.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2030)
7.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2019-2030)
6.2.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2019-2030)
7.3 Global Equine Pharmaceuticals and Supplements Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Equine Pharmaceuticals and Supplements Value Chain Analysis
8.1.1 Equine Pharmaceuticals and Supplements Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Equine Pharmaceuticals and Supplements Production Mode & Process
8.2 Equine Pharmaceuticals and Supplements Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Equine Pharmaceuticals and Supplements Distributors
8.2.3 Equine Pharmaceuticals and Supplements Customers
9 GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS ANALYZING MARKET DYNAMICS
9.1 Equine Pharmaceuticals and Supplements Industry Trends
9.2 Equine Pharmaceuticals and Supplements Industry Drivers
9.3 Equine Pharmaceuticals and Supplements Industry Opportunities and Challenges
9.4 Equine Pharmaceuticals and Supplements Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
